Role of cyclic 3′,5′-adenosine monophosphate in the regulation of chemical mediator release and cytokine production from cultured human mast cells

Journal of Allergy and Clinical Immunology

Volumn 103, Issue 5 SUPPL., 1999, Pages

  Shichijo, Michitaka ^a   Inagaki, Naoki ^a   Kimata, Masahiro ^a   Serizawa, Isao ^c   Saito, Hirohisa ^b   Nagai, Hiroichi ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^b NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^c KIRIN BREWERY CO LTD   (Japan)

Author keywords

Histamine; Leukotrienes; Mast cell

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CILOSTAZOL; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HISTAMINE; INTERLEUKIN 5; ISOPRENALINE; LEUKOTRIENE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; PHOSPHODIESTERASE INHIBITOR; PROSTAGLANDIN D2; ROLIPRAM; SALBUTAMOL; THEOPHYLLINE;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; HISTAMINE RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; KINETICS; MAST CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ADRENERGIC BETA-AGONISTS; BUCLADESINE; CELLS, CULTURED; CYCLIC AMP; CYTOKINES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HISTAMINE RELEASE; HUMANS; KINETICS; LEUKOTRIENES; MAST CELLS; PHOSPHODIESTERASE INHIBITORS; PROSTAGLANDIN D2;

EID: 0033027404     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(99)70157-0     Document Type: Article

References (39)

1. Saito H, Ebisawa M, Sakaguchi N, Onda T, Iikura Y, Yanagida M, et al. Characterization of cord-blood-derived human mast cells cultured in the presence of steel factor and interleukin-6. Int Arch Allergy Immunol 1995;107:63-5.
2. Saito H, Ebisawa M, Tachimoto H, Shichijo H, Fukagawa K, Matsumoto K, et al. Selective growth of human mast cells induced by steel factor, IL-6, and prostaglandin E2 from cord blood mononuclear cells. J Immunol 1996;157:343-50.
3. Shichijo M, Inagaki N, Nakai N, Kimata M, Nakahata T, Serizawa I, et al. The effects of anti-athma drugs on mediator release from cultured human mast cells. Clin Exp Allergy 1998;28:1228-36.
4. Ebisawa M, Shichijo M, Miura K, Tachimoto H, Katsunuma T, Onda T, et al. Human mast cells produce TNF-α, MIP-1α and IL-5 following activation through FcεRI [abstract]. J Allergy Clin Immunol 1995;95:219.
5. Yanagida M, Fukamachi H, Ohgami K, Kuwaki T, Ishii H, Uzumaki H, et al. Effects of T-helper 2-type cytokines, interleukin-3 (IL-3), IL-4, IL-5, and IL-6 on the survival of cultured human mast cells. Blood 1995;86:3705-14.
6. Igarashi Y, Kurosawa M, Ishikawa O, Miyachi Y, Saito H, Ebisawa M, et al. Characteristics of histamine release from cultured human mast cells. Clin Exp Allergy 1996;26:597-602.
7. Irani AA, Schecter NM, Craig SS, Deblois G, Schwartz LB. Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci USA 1986;83:4464-8.
8. Butchers PR, Fullarton JR, Skidmore IF, Vardey CJ, Wheeldon A. A comparison of the anti-anaphylactic activities of salbutamol and disodium cromoglycate in rat, the rat mast cells and in human lung tissue. Br J Pharmacol 1979;67:23-32.
9. Peters SP, Schulman ES, Schleimer RP, MacGlashan DW Jr, Newball HH, Lichtenstein LM. Dispersed human lung mast cells: pharmacologic aspects and comparison with human lung fragments. Am Rev Respir Dis 1982;126:1034-9.
10. Church MK, Young KD. The characteristics of inhibition of histamine from human lung fragments by sodium cromoglycate, salbutamol and chlorpromazine. Br J Pharmacol 1983;78:671-9.
11. Young KD, Church MK. Passive anaphylaxis in human lung fragments as a model for testing anti-allergic drugs: its variability and constraints. Int Arch Allergy Appl Immunol 1983;70:138-42.
12. Hughes JM, Seale JP, Temple DM. Effects of fenoterol on immunological release of leukotrienes and histamine from human lung in vitro: selective antagonism by β-adrenoceptor antagonists. Eur J Pharmacol 1983; 95:239-45.
13. Okayama Y, Church MK. Comparison of the modulatory effect of ketotifen, sodium cromoglycate, procaterol and salbutamol in human skin, lung and tonsil mast cells. Int Arch Allergy Immunol 1992;97:216-25.
14. Peachell PT, MacGlashan DW Jr, Lichtenstein LM, Schleimer RP. Regulation of human basophil and lung mast cell function by cyclic adenosine monophosphate. J Immunol 1988;140:571-9.
15. Undem BJ, Peachell PT, Lichtenstein LM. Isoprotenol-induced inhibi-tion of immunoglobulin E-mediated release of histamine and arachidonic acid metabolites from the human lung mast cells. J Pharmacol Exp Ther 1988;247:209-17.
16. Craig SS, Deblois G, Schwartz LB. Mast cells in human keloid, small intestine, and lung by an immunoperoxidase technique using a murine monoclonal antibody against tryptase. Am J Pathol 1986;124:427-35.
17. Yamatodani A, Fukuda H, Wada H, Iwaeda T, Watanabe T. High-performance liquid chromatographic determination of plasma and brain histamine without previous purification of biological samples: cationexchange chromatography coupled with post-column derivatization fluorometry. J Chrom 1985;344:115-23.
18. De Weck AL, Stadler BM, Urwyler A, Wehner HUU, Bühlman RP. Cellular allergen Stimulation test (CAST): a new dimension in allergy diagnostics. Allergy Clin Immunol News 1993;5:9-14.
19. Pradelles P, Grassi J, Maclouf J. Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay. Anal Chem 1985;57:1170-3.
20. Verghese MW, McConnell RT, Strickland AB, Gooding RC, Stimpson SA, Yamall DP, et al. Differential regulation of human monocyte-derived TNF-α and IL-1β by type IV cAMP - phosphodiesterase (cAMP - PDE) inhibitors. J Pharm Exp Ther 1994;272:1313-20.
21. Munoz E, Zubiaga AM, Merrow M, Sauter NP, Huber BT. Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation. J Exp Med 1990;172:95-103.
22. +T cells while decreasing IL-2 release and NF-AT induction. Int Immunol 1994;6:1333-43.
23. Ishizaka T, Hirata F, Sterk AR, Ishizaka K, Axelrod JA. Bridging of IgE receptors activates phospholipid methylation and adenylate cyclase in mast cell plasma membranes. Proc Natl Acad Sci USA 1981;78:6812-6.
24. Undem BJ, Torphy TJ, Goldman D, Chilton FH. Inhibition by adenosine 3′,5′-monophosphate of eicosanoid and platelet-activating factor biosynthesis in the mouse PT-18 mast cell. J Biol Chem 1990;265:6750-8.
25. Saito H, Ishizaka K, Ishizaka T. Effect of nonhydrolyzable guanosine phosphate on IgE-mediated activation of phospholipase C and histamine release from rodent mast cells. J Immunol 1989;143:250-8.
26. Foreman JC, Hallet MB, Mongar JL. The relationship between histamine secretion and calcium uptake by mast cells. J Physiol 1977;271:193-214.
27. White JR, Ishizaka T, Ishizaka K, Sha'afi RK. Direct demonstration of increased intracellular concentration of free calcium as measured by quin-2 in stimulated rat peritoneal mast cell. Proc Natl Acad Sci USA 1984;81:3978-82.
28. Yoshii N, Mio M, Tasaka K. Ca uptake and Ca releasing properties of the endoplasmic reticulum in rat peritoneal mast cells. Immunopharmacology 1988;16:107-13.
29. Kurosawa M, Parker CW. A phosphatidylinositol kinase in rat mast cell granules. J. Immunol 1986;136:616-22.
30. Sydbom A, Fredholm B, Uynas B. Evidence against a role of cyclic nucleotides in the regulation of anaphylactic histamine release in isolated rat mast cells. Acta Physiol Scand 1981;73:933-8.
31. Ennis M, Truneh A, White JR, Pearce FL. Inhibition of histamine secretion from mast cells. Nature 1981;289:186-7.
32. Louis R, Bury TH, Corhay JL, Radermecker M. LY 186655, a phosphodiesterase inhibitor, inhibits histamine release from human basophils, lung and skin fragments. Int J Immunopharmacol 1992;14:191-4.
33. Frossard N, Landry Y, Pauli G, Ruckstuhl M. Effects of cyclic AMP-and cyclic GMP- phosphodiesterase inhibitors on immunological release of histamine and on lung contraction. Br J Pharmacol 1981;73:933-8.
34. Peachell PT, Undem BJ, Shleimer RP, MacGlashan DW Jr, Lichtenstein LM, Cieslinski LB, et al. Preliminary identification and role of phosphodiesterases in human basophils. J Immunol 1992;148:2503-10.
35. Seldon PM, Barnes PJ, Meja K, Giembycz MA. Suppression of lipopolysaccharide-induced tumor necrosis factor-α generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylate cyclase. J Pharm Exp Ther 1995;48:747-57.
36. Barnes PJ, Pauwels RA. Theophylline in the management of asthma: Time for reappraisal? Eur Respir J 1994;7:579-91.
37. Twentyman OP, Finnerty JP, Holgate ST. The inhibitory effect of nebulized albuterol on the early and late asthmatic reactions and increase in airways responsiveness provoked by inhaled allergen in asthma. Am Rev Respir Dis 1991;144:782-7.
38. Twentyman OP, Sams VS, Holgate ST. Albuterol and nedocromil sodium affect airway and leukocyte responses to allergen. Am Rev Respir Dis 1993;147:1425-30.
39. Underwood DC, Matthews JK, Osborn RR, Bochnowicz S, Torphy TJ. The influence of endogenous catecholamines on the inhibitory effects of rolipram against early- and late-phase response to antigen in the guinea pig. J Pharm Exp Ther 1996;280:210-9.